Bristol Myers Squibb shared a post on LinkedIn:
“We’re looking forward to joining the hematology community at the European Hematology Association (EHA) 2026 Congress, an important forum for sharing insights and research to advance the future of care for hematologic conditions.
Our team will showcase data across our oncology and cell therapy portfolio and contribute to ongoing scientific dialogue through a series of symposiums.
Learn more about our work in hematology.”
Other articles about Hematology on OncoDaily.